PFIZER

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

482

Firms Hired

Active Period

1999–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	9	3
2025	—	12	4
2024	—	16	4
2023	—	18	5
2022	—	20	5
2021	—	22	6
2020	—	24	6
2019	—	25	6
2018	—	22	6
2017	—	17	4
2016	—	18	4
2015	—	20	4
2014	—	17	4
2013	—	19	4
2012	—	15	4
2011	—	12	3
2010	—	9	3
2009	—	12	3
2008	—	21	6
2007	—	16	9
2006	—	26	15
2005	—	21	14
2004	—	24	14
2003	—	23	12
2002	—	10	5
2001	—	12	8
2000	—	8	6
1999	—	14	7

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
WILLIAMS AND JENSEN, PLLC	—	90
TARPLIN, DOWNS & YOUNG, LLC	—	37
CORNERSTONE GOVERNMENT AFFAIRS, INC.	—	74
FEDERAL HEALTH POLICY STRATEGIES	—	22
PALMETTO GROUP	—	12
LINCOLN POLICY GROUP	—	13
LENT SCRIVNER & ROTH LLC	—	11
PARVEN POMPER STRATEGIES, INC.	—	12
PARRY, ROMANI, DECONCINI & SYMMS	—	7
RICCHETTI INCORPORATED	—	6
KESSLER & ASSOCIATES BUSINESS SERVICES	—	14
THE RABEN GROUP	—	19
DAVIDSON & COMPANY	—	10
CAPITOL HEALTH GROUP, LLC	—	10
RESOLUTION PUBLIC AFFAIRS, LLC	—	6

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	370
HOUSE OF REPRESENTATIVES	367
Health & Human Services, Dept of (HHS)	139
Centers For Disease Control & Prevention (CDC)	71
Centers For Medicare and Medicaid Services (CMS)	46
White House Office	21
Office of Management & Budget (OMB)	15
Executive Office of the President (EOP)	13
Commerce, Dept of (DOC)	3
Federal Motor Carrier Safety Administration	3
Transportation, Dept of (DOT)	3
Patent & Trademark Office (PTO)	2
Education, Dept of	1
Federal Aviation Administration (FAA)	1
Homeland Security, Dept of (DHS)	1
Treasury, Dept of	1
U.S. Trade Representative (USTR)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	309
Medicare/Medicaid	Medicare/Medicaid	165
Budget/Appropriations	Budget/Appropriations	148
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	119
Trade (domestic/foreign)	Trade (domestic/foreign)	81
Copyright/Patent/Trademark	Copyright/Patent/Trademark	47
Pharmacy	Pharmacy	31
Torts	Torts	29
Defense	Defense	26
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	19
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	13
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	9
Advertising	Advertising	6
Law Enforcement/Crime/Criminal Justice	Law Enforcement/Crime/Criminal Justice	6
Science/Technology	Science/Technology	5
Government Issues	Government Issues	5
Transportation	Transportation	4
Insurance	Insurance	2
Aviation/Airlines/Airports	Aviation/Airlines/Airports	2
Postal	Postal	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5509119th Congress

Safe Step Act

2026 · third_quarter · Firm: RESOLUTION PUBLIC AFFAIRS, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug development and pricing, generally vaccine safety and access, generally the 340B program, Issues related to pharmacy benefit managers, generally. H.R. 5509, the Safe Step Act

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5509

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1

H.R. 5509119th Congress

Safe Step Act

2026 · second_quarter · Firm: RESOLUTION PUBLIC AFFAIRS, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug development and pricing, generally vaccine safety and access, generally the 340B program, Issues related to pharmacy benefit managers, generally. H.R. 5509, the Safe Step Act

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5509

H.R. 5509119th Congress

Safe Step Act

2026 · first_quarter · Firm: RESOLUTION PUBLIC AFFAIRS, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug development and pricing, generally vaccine safety and access, generally the 340B program, Issues related to pharmacy benefit managers, generally. H.R. 5509, the Safe Step Act

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5509

Show 21 more cited filings

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Tax issues affecting the pharmaceutical industry including international tax; including tax issues under consideration for reconciliation legislation and H.R. 1, One Big Beautiful Bill Act". Vaccine excise tax issues and VICP. P.L. 119-21.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals. H.R. 1; issues related to biopharmaceutical drug pricing, particularly related to MFN.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2025 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Tax issues affecting the pharmaceutical industry including international tax; including tax issues under consideration for reconciliation legislation and H.R. 1, One Big Beautiful Bill Act". Vaccine excise tax issues and VICP.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1

H.R. 1458118th Congress

Access to Prescription Digital Therapeutics Act of 2023

2024 · fourth_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458) H.R. 8816, the American Medical Innovation and Investment Act

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1458

H.R. 8816118th Congress

American Medical Innovation and Investment Act of 2024

2024 · fourth_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458) H.R. 8816, the American Medical Innovation and Investment Act

Client expense: — · Firm income: $60,000

Matched citations: H.R. 8816

H.R. 1458118th Congress

Access to Prescription Digital Therapeutics Act of 2023

2024 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency Act H.R. 8816, the American Medical Innovation and Investment Act

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1458

H.R. 4307118th Congress

Medical Supply Chain Resiliency Act

2024 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency Act H.R. 8816, the American Medical Innovation and Investment Act

Client expense: — · Firm income: $60,000

Matched citations: H.R. 4307

H.R. 8816118th Congress

American Medical Innovation and Investment Act of 2024

2024 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency Act H.R. 8816, the American Medical Innovation and Investment Act

Client expense: — · Firm income: $60,000

Matched citations: H.R. 8816

S. 2115118th Congress

Medical Supply Chain Resiliency Act

2024 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency Act H.R. 8816, the American Medical Innovation and Investment Act

Client expense: — · Firm income: $60,000

Matched citations: S. 2115

H.R. 1458118th Congress

Access to Prescription Digital Therapeutics Act of 2023

2024 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency ActH.R. 8816, the American Medical Innovation and Investment Act

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1458

H.R. 4307118th Congress

Medical Supply Chain Resiliency Act

2024 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency ActH.R. 8816, the American Medical Innovation and Investment Act

Client expense: — · Firm income: $60,000

Matched citations: H.R. 4307

S. 2115118th Congress

Medical Supply Chain Resiliency Act

2024 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)S. 2115/H.R. 4307 the Medical Supply Chain Resiliency ActH.R. 8816, the American Medical Innovation and Investment Act

Client expense: — · Firm income: $60,000

Matched citations: S. 2115

H.R. 1458118th Congress

Access to Prescription Digital Therapeutics Act of 2023

2024 · first_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1458

H.R. 1458118th Congress

Access to Prescription Digital Therapeutics Act of 2023

2023 · fourth_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1458

H.R. 1458118th Congress

Access to Prescription Digital Therapeutics Act of 2023

2023 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1458

H.R. 1458118th Congress

Access to Prescription Digital Therapeutics Act of 2023

2023 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458)

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1458

H.R. 1319117th Congress

American Rescue Plan Act of 2021

2022 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages. Drug pricing proposals including H.R. 3. Medicare rebate reform, the 340B program, and proposals to impose "most favored nation" pricing on Medicare Part B and D. COVID-19 relief proposals. American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169). H.R. 3. H.R. 19. HR 3927. S. 2082. Consolidated Appropriations Act, FY 23 (P.L. 117-328). PASTEUR Act H.R. 3932, S. 2076.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1319

Source: Senate LDA

PFIZER — Lobbying Disclosure | Poliscope